Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122064583-122144308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 141.4;Hepatocytes: 223.2;Oligodendrocytes: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"testis cancer: 37.8"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		Yes	No		19000		"Cluster 15: Liver - Metabolism"	"Cluster 6: BEWO - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.9;kidney: 133.3;liver: 345.6;pancreas: 138.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 266.3;Horizontal cells: 68.6;Inhibitory neurons: 92.8;Oligodendrocyte precursor cells: 73.6;Proximal tubular cells: 76.7"	"Cancer enhanced"	"Detected in all"		"glioma: 27.3;liver cancer: 26.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Pancreas - Exocrine glandular cells, Prostate - Prostate glandular cells, Testis - Sertoli cells, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria		No	No		2100000	"Cluster 14: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (5.36e-5)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"
ABHD6		ENSG00000163686	"Abhydrolase domain containing 6, acylglycerol lipase"	Q9BV23	3	58237532-58295693	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 53.8;Oligodendrocytes: 83.6;Proximal enterocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Bone cancer: 57.9"	"Skin - Keratinocyte (other), Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017283, HPA073225"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 45: Intestine - Brush border"	"Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles	Nucleoplasm	"HPA017283: AB_1844452, HPA073225: AB_2686583"	"unprognostic (4.20e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (1.13e-4)"	"unprognostic (2.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (1.11e-11)"	"unprognostic (1.94e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.31e-2)"
AC009070.1		ENSG00000286221	"Novel protein"		16	80828736-81006894	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Low region specificity"	"Detected in all"													NA	NA					"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 29: Hepatocytes - Metabolism"																				
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 204.5;Basal respiratory cells: 269.8;Hepatocytes: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 15: Non-specific - Protein binding"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"
ACSS2	"ACAS2, AceCS, ACS, ACSA, dJ1161H23.1"	ENSG00000131069	"Acyl-CoA synthetase short chain family member 2"	Q9NR19	20	34872146-34927962	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 117.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 125.5;Hepatocytes: 109.2;Intestinal goblet cells: 121.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 34.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 22.6;granulocytes: 34.3;monocytes: 21.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Alveolar cells type 2, Skin - Sebaceous gland cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004141	Approved					NA	NA		16000	"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 29: Hepatocytes - Metabolism"			"HPA004141: AB_1078094"	"unprognostic (1.97e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.42e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.54e-1)"
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 111.8;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Mesothelial cells, Colon - Enteric glia cells, Skin - Keratinocyte (other), Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Rabdoid cancer - Embryonic development"	"Cluster 29: Hepatocytes - Metabolism"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230690776-230745576	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1603.7"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 993.2;Hepatocytes: 1921.0;Kupffer cells: 509.9"	"Cancer enriched"	"Detected in all"	4	"liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"liver cancer: 190.4"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	NA	NA	5940000	65000000000		"Cluster 15: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186613060-186621318	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease variant, Hypotrichosis, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4302	"liver: 5817.6"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 1133.3"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	16	"liver cancer: 532.8"	"Liver - Hepatocytes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	110000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"	
AMDHD1	MGC35366	ENSG00000139344	"Amidohydrolase domain containing 1"	Q96NU7	12	95943331-95968720	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Histidine metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 60.7;skeletal muscle: 27.3"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 134.6"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Esophageal cancer: 67.9;head and neck cancer: 73.7"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039720, HPA040149"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		No	NA		1400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039720: AB_10672967, HPA040149: "	"unprognostic (4.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-1)"
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425545	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 141.9;Hepatocytes: 135.5;Late spermatids: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA064339, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 36: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: AB_2672869, HPA064339: , HPA077835: AB_2686856"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 409.8"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 126.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"liver cancer: 9.4"	"Breast - Adipocytes (Breast)"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	NA	NA	836000	350000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 710.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Macrophages, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	143	"intestine: 304.3;liver: 1191.0"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 2317.4;Proximal enterocytes: 1362.5"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"liver cancer: 176.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	NA	NA	1490000000000	100000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44946035-44949565	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease variant, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"liver: 9641.4"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 830.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	30	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	30	"NK-cells: 3.2"	"Cancer enhanced"	"Detected in many"		"Brain cancer: 65.9;Leukemia: 75.8;liver cancer: 82.8"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pancreas - Macrophages"									HPA055877	Supported				"Secreted to blood"	NA	NA	43000000000	49000000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA055877: AB_2682953"	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360568-56362857	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	344	"liver: 416.7"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 302.8;Kupffer cells: 79.6"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes, Prostate - Prostate glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	18000000000	2200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"liver: 840.7"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 773.1"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 110.0;myeloid DC: 64.1"	"Group enriched"	"Detected in many"	51	"dendritic cells: 64.1;monocytes: 110.0"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 103.7"	"Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Hepatocytes, Lung - Neutrophil_2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA		14000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"
ATF5		ENSG00000169136	"Activating transcription factor 5"	Q9Y2D1	19	49928702-49933935	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 2479.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1306.8"	"Cancer enriched"	"Detected in all"	7	"liver cancer: 200.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 24.0;intermediate monocyte: 22.4;myeloid DC: 14.3;plasmacytoid DC: 38.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 38.5;monocytes: 24.0"	"Cancer enhanced"	"Detected in all"		"lymphoma: 438.5"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030187	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA030187: AB_10601666"	"unprognostic (2.09e-2)"	"prognostic favorable (1.14e-4)"	"unprognostic (9.38e-3)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (3.39e-7)"	"unprognostic (3.06e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.51e-1)"
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109238	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 112.1;Leydig cells: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	NA	NA	5500000000	15000000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB026172: , HPA011338: AB_1847111"	"prognostic favorable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 189.1;Hepatocytes: 327.6;Hofbauer cells: 244.4;Kupffer cells: 99.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Group enriched"	"Detected in many"	4	"liver cancer: 11.7;Myeloma: 15.4;thyroid cancer: 4.9"	"Adipose subcutaneous - Macrophages, Liver - Hepatocytes, Skin - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 4761.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 641.9;Hepatocytes: 3195.0;Kupffer cells: 731.3;Thymic epithelial cells: 2259.7"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 1213.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"non-classical monocyte: 13.3"	"Lineage enriched"	"Detected in many"	4	"monocytes: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 248.6"	"Liver - Hepatocytes, Lung - Fibroblast_2, Thyroid - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	NA	NA	1260000000000	200000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 115.8;liver: 336.8"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 6.9;Thymic epithelial cells: 8.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 7.2;Myeloma: 7.8"	"Breast - Breast glandular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 221.5;liver: 385.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.9;Hepatocytes: 7.2;Kupffer cells: 3.0;Plasma cells: 1.9;Thymic epithelial cells: 13.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 6.1;Myeloma: 4.1"	"Liver - Hepatocytes"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 1918.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 307.9;Hepatocytes: 862.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.5"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.5"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 7.1"	"Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	NA	NA	30800000000	28000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050275	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 433.7"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 441.1"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"liver cancer: 19.6"	"Liver - Hepatocytes, Thyroid - Fibroblasts"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA029339	Supported				"Secreted to blood"	NA	NA	113000000000	39000000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 665.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.0;Hepatocytes: 327.4;Kupffer cells: 55.9;Late spermatids: 54.1;Leydig cells: 120.4"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	195	"liver: 635.7"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 260.8"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 1.4"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"	
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56966140	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	156	"liver: 840.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 250.0"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	22	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 1.3"	"Liver - Hepatocytes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023694	Supported				"Secreted to blood"	NA	NA		6700000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favorable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"	
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 564.4"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1048.9"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Gastric cancer: 7.2;liver cancer: 2.2"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"	NA	NA		2800000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"			"HPA046269: AB_2679606"	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39424868	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	288	"liver: 1397.0"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1962.5"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	NA	NA	69600000000	64000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"
CBS	HIP4	ENSG00000160200	"Cystathionine beta-synthase"	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 174.9;pancreas: 99.0"	"Cell type enhanced"	"Detected in some"		"Exocrine glandular cells: 1.1;Hepatocytes: 2.6;Paneth cells: 2.4;Proximal enterocytes: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	51	"neutrophil: 5.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.0"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"							HPA001223	Supported		Approved	Nucleoli,Vesicles		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"
CERS2	"FLJ10243, LASS2, SP260"	ENSG00000143418	"Ceramide synthase 2"	Q96G23	1	150960583-150975003	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 732.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 169.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Macrophages, Liver - Hepatocytes, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027262, HPA078737"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 18: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA027262: AB_1852717, HPA078737: "	"unprognostic (1.01e-1)"	"unprognostic (2.70e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.85e-1)"
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"epididymis: 67.5"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 1.5;Cholangiocytes: 1.9;Collecting duct cells: 3.9;Excitatory neurons: 1.4;Hepatocytes: 6.7;Oligodendrocyte precursor cells: 1.9;Oligodendrocytes: 3.8"	"Cancer enriched"	"Detected in single"	5	"liver cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"							"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"		
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196832189	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	272	"liver: 2081.3"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 225.8;Kupffer cells: 83.1"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Sarcoma: 3.2;thyroid cancer: 5.5"	"Liver - Hepatocytes"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101"	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favorable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774813-196795407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	582	"liver: 505.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 141.1"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.9"															"Secreted to blood"	NA	NA	582000000	3100000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 29: TT & NCI-H1385 - Synaptic signal transduction"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196888014-196918713	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	432	"liver: 123.9"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 37.0"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"					"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		170000000		"Cluster 62: Liver - Hemostasis"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"									"unprognostic (5.97e-1)"	"prognostic favorable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1675	"liver: 167.5"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 96.2"	"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"HPA038915, HPA040726"	Supported				"Secreted to blood"	NA	NA		1900000000		"Cluster 62: Liver - Hemostasis"	"Cluster 61: Liver - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA038915: AB_2676269, HPA040726: AB_2677101"							"unprognostic (9.12e-3)"										
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109801999	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1098.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 109.7;Hepatocytes: 459.9;Muller glia cells: 116.0;Proximal tubular cells: 197.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 90.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Endothelial cells, Skin - Endothelial cells"									"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	NA	NA		12000000000		"Cluster 85: Liver - Metabolism"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 29: Hepatocytes - Metabolism"			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (6.06e-4)"
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 298.8;Glandular and luminal cells: 439.7;Hepatocytes: 1435.0;Kupffer cells: 660.4;Muller glia cells: 604.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 46.8;liver cancer: 40.8;ovarian cancer: 57.3"	"Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081869	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"liver: 81.6"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 35.8"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"skin cancer: 33.8"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		13000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 29: Hepatocytes - Metabolism"						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"		
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"liver: 9388.5"	"Group enriched"	"Detected in some"	5	"Ductal cells: 1221.1;Hepatocytes: 3048.6"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Gastric cancer: 1.2"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.9;Hepatocytes: 11.0;Proximal tubular cells: 1.9;Salivary duct cells: 3.9;Thymic epithelial cells: 2.8"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"
CYP2A7	CYP2A	ENSG00000198077	"Cytochrome P450 family 2 subfamily A member 7"	P20853	19	40875439-40882752	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	71	"liver: 152.5"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 89.7"	"Group enriched"	"Detected in some"	238	"breast cancer: 9.2;liver cancer: 25.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"CAB033510, HPA046713, HPA047262"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005"	"unprognostic (2.18e-1)"				"unprognostic (3.60e-2)"		"unprognostic (2.65e-3)"	"unprognostic (8.89e-2)"		"unprognostic (1.39e-2)"	"unprognostic (3.95e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.99e-2)"		"unprognostic (1.06e-2)"	
CYP3A7	"CP37, P450-HFLA"	ENSG00000160870	"Cytochrome P450 family 3 subfamily A member 7"	P24462	7	99705036-99735196	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 304.9"	"Group enriched"	"Detected in some"	10	"Cholangiocytes: 88.5;Hepatocytes: 33.4"	"Cancer enriched"	"Detected in some"	43	"liver cancer: 38.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	Vesicles	"HPA072245: , HPA075539: "	"unprognostic (8.10e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-11)"	"unprognostic (2.02e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.34e-3)"
CYP3A7-CYP3A51P		ENSG00000282301	"CYP3A7-CYP3A51P readthrough"		7	99684957-99735102	"Metabolic proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	8	"liver: 12.7"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 3.8;Hepatocytes: 1.1"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"HPA072245, HPA075539"			Approved	Vesicles,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 52: Spermatids - Smell perception"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	Vesicles	"HPA072245: , HPA075539: "																	
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.9;liver: 72.3"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 57.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"Gallbladder cancer: 213.3"	"Liver - Hepatocytes"									"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 61: Liver - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862"	"prognostic favorable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112153-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 204.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.0;Kupffer cells: 82.7;Oligodendrocytes: 50.1;Squamous epithelial cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Liver - Hepatocytes, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"
DHCR24	"DCE, KIAA0018, seladin-1"	ENSG00000116133	"24-dehydrocholesterol reductase"	Q15392	1	54849627-54887195	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 1129.5;liver: 623.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.3;Alveolar cells type 2: 502.0;Hepatocytes: 834.8;Kupffer cells: 367.5;Suprabasal keratinocytes: 289.8;Theca cells: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Testis - Leydig cells"	"Low region specificity"	"Detected in all"							"HPA017981, CAB037247, HPA063005"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 68: Kidney - Mixed function"	"Cluster 29: Hepatocytes - Metabolism"			"CAB037247: AB_796187, HPA017981: AB_2732422, HPA063005: AB_2684919"	"unprognostic (2.88e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.69e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.82e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.97e-2)"
DHCR7	SLOS	ENSG00000172893	"7-dehydrocholesterol reductase"	Q9UBM7	11	71428193-71452868	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 161.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 102.9;Basal respiratory cells: 77.6;Granulosa cells: 78.1;Hepatocytes: 130.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Lung - Alveolar cells type 2, Skin - Sebaceous gland cells, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044280	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA044280: AB_10794893"	"unprognostic (1.76e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-3)"	"unprognostic (8.57e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.45e-2)"	"prognostic favorable (6.93e-7)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (5.67e-4)"
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 105.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 36: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"
EBP	"CDPX2, CHO2, CPX, CPXD"	ENSG00000147155	"EBP cholestenol delta-isomerase"	Q15125	X	48521799-48528716	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase	"Cataract, Disease variant, Dwarfism, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 328.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 641.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"							HPA003130	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 48: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	"Nuclear membrane, Endoplasmic reticulum"		"HPA003130: AB_1078717"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.39e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.36e-1)"
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	11	"kidney: 144.3;liver: 344.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 280.2;Kupffer cells: 55.9;Proximal tubular cells: 126.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 68: Kidney - Mixed function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA036401: AB_10670165, HPA042021: AB_2677801"	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"
ELOVL6	"FLJ23378, LCE, MGC5487"	ENSG00000170522	"ELOVL fatty acid elongase 6"	Q9H5J4	4	110045846-110199199	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.3;Hepatocytes: 90.8;Inhibitory neurons: 76.7;Oligodendrocytes: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.4;MAIT T-cell: 2.6;memory CD4 T-cell: 1.0;memory CD8 T-cell: 1.3;naive CD8 T-cell: 1.0;NK-cell: 3.3"	"Group enriched"	"Detected in many"	21	"NK-cells: 3.3;T-cells: 2.6"	"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Endothelial cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042355	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 45: Non-specific - Cell proliferation"	"Cluster 29: Hepatocytes - Metabolism"			"HPA042355: AB_10796577"	"unprognostic (3.92e-2)"	"unprognostic (9.47e-2)"	"prognostic favorable (6.74e-4)"	"unprognostic (8.09e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.32e-2)"
EPO	EP	ENSG00000130427	Erythropoietin	P01588	7	100720468-100723700	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Predicted secreted proteins"	"Erythrocyte maturation"	Hormone	"Cancer-related genes, Congenital erythrocytosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.2"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 16.9;Hepatocytes: 18.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.7;renal cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010336	Supported				"Secreted to blood"	NA	NA	12300			"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB010336: AB_2098408"	"unprognostic (2.93e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (2.18e-6)"	"unprognostic (4.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.34e-1)"
ERG28	"C14orf1, NET51"	ENSG00000133935	"Ergosterol biosynthesis 28 homolog"	Q9UKR5	14	75649791-75660876	"Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 258.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043172	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 46: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA043172: AB_10793942"	"unprognostic (2.68e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.25e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (4.30e-5)"	"unprognostic (1.28e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-3)"	"unprognostic (2.20e-1)"
ESRRA	"ERR1, ERRa, ERRalpha, ESRL1, NR3B1"	ENSG00000173153	"Estrogen related receptor alpha"	P11474	11	64305497-64316743	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 195.3"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 252.1;Kupffer cells: 206.6;Proximal enterocytes: 183.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053785, HPA077297"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 58: Non-specific - Basic cellular processes"	"Cluster 29: Hepatocytes - Metabolism"	"Nucleoplasm, Nucleoli fibrillar center, Microtubules"	"Cytokinetic bridge"	"HPA053785: AB_2682260, HPA077297: "	"unprognostic (7.63e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.34e-7)"	"unprognostic (3.43e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.20e-2)"
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 243.2"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 70.0"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 2.1"	"Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039808			Approved	Vesicles	"Secreted to blood"	NA	NA		4400000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"HPA039808: AB_2676693"			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favorable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"		
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402141-177409564	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	226	"liver: 604.6"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 379.9"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;eosinophil: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.6;monocytes: 1.2"	"Low cancer specificity"	"Detected in many"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA003825	Approved				"Secreted to blood"	NA	NA	1040000	7000000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1518	"liver: 1217.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 851.0"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"liver cancer: 63.5"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	NA	NA	108000000000	41000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 160.2"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 120.7"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"breast cancer: 4.0;liver cancer: 8.8"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	NA	NA	351000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2467	"liver: 704.9"	"Group enriched"	"Detected in some"	14	"Hepatocytes: 525.9;Kupffer cells: 238.0"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		8200000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"										"prognostic favorable (6.69e-4)"										
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583128-154590745	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	388	"liver: 18396.9"	"Cell type enriched"	"Detected in some"	24	"Hepatocytes: 13790.7"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"liver cancer: 216.5"	"Liver - Hepatocytes, Stomach - Parietal cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	407000000	140000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Enzymes"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavorable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"		
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	373	"liver: 17944.9"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 16176.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"liver cancer: 197.8"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		110000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Enzymes"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"		
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16556.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 9963.2"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"liver cancer: 254.5"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	267000000000	73000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 40: Non-specific - Enzymes"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavorable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"
FGGY	FLJ10986	ENSG00000172456	"FGGY carbohydrate kinase domain containing"	Q96C11	1	59296638-59810647	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 77.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 122.6;Cholangiocytes: 348.4;Hepatocytes: 163.3;Skeletal myocytes: 201.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054971, HPA075137"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	"Nuclear bodies"	"HPA054971: , HPA075137: "	"unprognostic (4.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.80e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.36e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.78e-1)"
FGL1	"HFREP-1, HPS"	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 4163.9"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 7130.1"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	4	"liver cancer: 59.7"	"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA		57000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"
GBP7	"FLJ38822, GBP4L"	ENSG00000213512	"Guanylate binding protein 7"	Q8N8V2	1	89131742-89176009	"Predicted intracellular proteins"	"Antiviral defense, Immunity"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	156	"liver: 100.2"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 13.9"	"Cancer enriched"	"Detected in single"	58	"liver cancer: 10.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									HPA051245	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"			"HPA051245: AB_2681404"	"unprognostic (4.22e-5)"	"unprognostic (7.32e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.66e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.15e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.35e-2)"
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC vitamin D binding protein"	P02774	4	71741696-71804041	"Metabolic proteins, Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 8260.1"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 1699.5;Hepatocytes: 2798.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	13	"liver cancer: 30.5"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	NA	NA	143000000000	73000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favorable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavorable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"		
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"kidney: 50.0;liver: 169.6"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 56.9"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Beta cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"
GLS2	"GA, GLS, hLGA, LGA"	ENSG00000135423	"Glutaminase 2"	Q9UI32	12	56470944-56488414	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 204.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.7;Hepatocytes: 51.0;Inhibitory neurons: 30.8"	"Cancer enriched"	"Detected in single"	4	"liver cancer: 1.7"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes, Prostate - Prostate basal glandular cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038608	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA038608: AB_10673176"	"unprognostic (5.59e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.98e-6)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.65e-5)"	"unprognostic (1.42e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.44e-2)"
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149865-112215377	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 305.7;liver: 144.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 87.9;Hepatocytes: 149.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Skin - Adipocytes (Skin), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 50.0;Excitatory neurons: 61.6;Hepatocytes: 81.5;Inhibitory neurons: 76.5;Oligodendrocyte precursor cells: 31.8"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"lymphoma: 6.0"	"Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 29: Hepatocytes - Metabolism"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"
GYS2		ENSG00000111713	"Glycogen synthase 2"	P54840	12	21536107-21604847	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"liver: 173.8"	"Group enriched"	"Detected in some"	5	"Astrocytes: 5.7;Excitatory neurons: 4.8;Hepatocytes: 7.0;Inhibitory neurons: 7.6;Microglial cells: 3.6;Oligodendrocyte precursor cells: 4.8;Oligodendrocytes: 2.8"	"Cancer enriched"	"Detected in single"	29	"liver cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039482	Approved					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 61: Liver - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA039482: AB_10795107"	"unprognostic (7.22e-3)"	"unprognostic (2.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.16e-1)"	"prognostic favorable (7.62e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-4)"
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 437.3"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 121.3;Ductal cells: 35.9;Hepatocytes: 187.9;Kupffer cells: 53.4"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 17.5"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	NA	NA	20200000000	4400000000		"Cluster 62: Liver - Hemostasis"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"liver: 198.2;skin 1: 61.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 98.9"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 56.9;neutrophil: 73.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 73.3"	"Cancer enhanced"	"Detected in some"		"Leukemia: 6.4;liver cancer: 3.5"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Skin - Keratinocyte (granular), Stomach - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol		NA	NA		280000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"
HJV	"haemojuvelin, hemojuvelin, HFE2, HFE2A, JH, RGMC"	ENSG00000168509	"Hemojuvelin BMP co-receptor"	Q6ZVN8	1	146017468-146036746	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"liver: 239.6;skeletal muscle: 591.1;tongue: 291.6"	"Group enriched"	"Detected in some"	15	"Cardiomyocytes: 61.7;Hepatocytes: 179.1;Skeletal myocytes: 76.2"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 87.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 1.3;liver cancer: 1.0;Sarcoma: 1.1"	"Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA		69000		"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (2.30e-1)"			"unprognostic (6.98e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.96e-8)"	"unprognostic (6.61e-2)"	"unprognostic (2.72e-1)"		"unprognostic (1.76e-2)"
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43287470-43313512	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 390.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 401.5;Hepatocytes: 446.5;Kupffer cells: 286.3;Suprabasal keratinocytes: 346.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		470000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: AB_2675380, HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favorable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"
HPN	TMPRSS1	ENSG00000105707	Hepsin	P05981	19	35040506-35066573	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 200.5;liver: 866.2;pancreas: 272.1"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 378.7;Proximal tubular cells: 164.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 127.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"liver cancer: 21.4;prostate cancer: 58.4"	"Breast - Breast glandular cells, Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Skin - Outer root sheath cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006804	Approved					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 24: Prostate cancer - Lipid metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA006804: AB_1079046"	"unprognostic (6.74e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (5.45e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.96e-2)"
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	908	"liver: 5440.6"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 5001.6"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 3.5;liver cancer: 8.7"	"Breast - Breast glandular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016725, HPA065318, HPA068847"	Approved				"Secreted to blood"	NA	NA	425000000000	190000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"CAB016725: , HPA065318: , HPA068847: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678234	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease variant, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	173	"liver: 5433.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 401.6"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	NA	NA	120000000000	28000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA050269: AB_2681068, HPA054598: AB_2682539"		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favorable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"
HSD17B12	"KAR, SDR12C1"	ENSG00000149084	"Hydroxysteroid 17-beta dehydrogenase 12"	Q53GQ0	11	43680680-43856617	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016427	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 58: Non-specific - Basic cellular processes"	"Cluster 29: Hepatocytes - Metabolism"			"HPA016427: AB_1844347"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (2.99e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.16e-2)"	"unprognostic (7.54e-2)"	"prognostic favorable (2.10e-8)"	"unprognostic (6.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"
HSD17B7	"PRAP, SDR37C1"	ENSG00000132196	"Hydroxysteroid 17-beta dehydrogenase 7"	P56937	1	162790702-162812817	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.2"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047496	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 29: Hepatocytes - Metabolism"			"HPA047496: AB_2680068"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.47e-5)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.17e-2)"
IDI1		ENSG00000067064	"Isopentenyl-diphosphate delta isomerase 1"	Q13907	10	1039152-1049119	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039169	Approved					NA	NA		28000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 67: Non-specific - Mitochondria & RNA binding"	"Cluster 29: Hepatocytes - Metabolism"			"HPA039169: AB_10674280"	"unprognostic (1.61e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.72e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.72e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.61e-2)"
INHBC		ENSG00000175189	"Inhibin subunit beta C"	P55103	12	57434784-57452062	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	172	"liver: 165.0"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 44.9"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"lymphoma: 2.0;Myeloma: 4.9"	"Liver - Hepatocytes, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050755			Approved	Cytosol	"Secreted to blood"	NA	NA		21000000		"Cluster 62: Liver - Hemostasis"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol		"HPA050755: "	"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin subunit beta E"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"liver: 148.4"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 33.8;Kupffer cells: 10.9"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Region enhanced"	"Detected in some"		"cerebellum: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"Myeloma: 85.3"	"Skeletal muscle - Skeletal myocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		3500000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777595-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	782	"liver: 1504.9"	"Cell type enriched"	"Detected in some"	18	"Hepatocytes: 803.2"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	NA	NA	4490000	59000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favorable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703316-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	668	"liver: 2156.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 410.8"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	30	"liver cancer: 159.6"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		32000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"		"HPA059150: AB_2683930"	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favorable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	97	"liver: 792.7"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 931.3;Kupffer cells: 832.0"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"liver cancer: 6.0"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Lung - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Testis - Late spermatids, Thyroid - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"	NA	NA		9100000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain 4"	Q14624	3	52812962-52830688	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"liver: 1863.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.6;Hepatocytes: 93.0;Kupffer cells: 35.1;Late spermatids: 161.5"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Adipose subcutaneous - Smooth muscle cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	3060000	58000000000	"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1338.5"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 392.6"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 7.8;thyroid cancer: 2.8"	"Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Thyroid - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 20: Connective tissue cells - ECM organization"	"Cluster 29: Hepatocytes - Metabolism"			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 34.9"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610582	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"epididymis: 50.1"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 27.8"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 0.8;liver cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Fibroblasts"	"Not detected"	"Not detected"												"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 2: DU4475 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536402-4540036	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 944.2"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 628.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 285.2"	"Lineage enriched"	"Detected in many"	44	"granulocytes: 285.2"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Neutrophils, Heart muscle - Neutrophils"	"Low region specificity"	"Detected in single"							"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	21000000000	42000000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.60e-2)"
LRRC3	"C21orf102, C21orf30, DKFZP434C128, LRRC3DN"	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455510-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 15.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 7.7;Hepatocytes: 24.2;Schwann cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Liver - Hepatocytes, Skeletal muscle - Fibroblasts"	"Low region specificity"	"Detected in all"							HPA017975	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 10: Ovarian & Endometrial cancers - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"
LSS	OSC	ENSG00000160285	"Lanosterol synthase"	P48449	21	46188141-46228824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Isomerase	"Cataract, Disease variant, Hypotrichosis, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 128.9;Kupffer cells: 87.5;Oligodendrocytes: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032060, HPA032062, CAB034116"	Supported					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 15: Liver - Metabolism"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"			"CAB034116: AB_2138611, HPA032060: AB_10671085, HPA032062: AB_2674134"	"unprognostic (2.78e-3)"	"unprognostic (8.53e-3)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.34e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.07e-4)"
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 90.5;Enteroendocrine cells: 83.8;Hepatocytes: 201.1;Kupffer cells: 87.5;Proximal enterocytes: 93.9;Skeletal myocytes: 49.5"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 21.4"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"
MMAB	"cblB, CFAP23"	ENSG00000139428	"Metabolism of cobalamin associated B"	Q96EY8	12	109553715-109573580	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 242.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Supported		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA039017: AB_10673603"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.55e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.65e-2)"
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 87.2;Hepatocytes: 106.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 15: Non-specific - Protein binding"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"
MSMO1	"DESP4, ERG25, SC4MOL"	ENSG00000052802	"Methylsterol monooxygenase 1"	Q15800	4	165327667-165343164	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 575.6"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 418.6;Hepatocytes: 471.9;Kupffer cells: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055073, HPA056127"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA055073: , HPA056127: AB_2683045"	"unprognostic (5.76e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.35e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (9.21e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.40e-1)"
MST1	"D3F15S2, DNF15S2, HGFL, MSP, NF15S2"	ENSG00000173531	"Macrophage stimulating 1"		3	49683947-49689501	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in all"	10	"liver: 927.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 198.3;Proximal enterocytes: 54.8;Proximal tubular cells: 42.9;Thymic epithelial cells: 45.4"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Skeletal muscle - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024036	Approved				"Secreted to blood"	NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA024036: AB_1854147"	"unprognostic (5.13e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.42e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.68e-3)"
MT1B	"MT1, MT1Q"	ENSG00000169688	"Metallothionein 1B"	P07438	16	56651886-56653204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"liver: 22.9"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 4.5;Hepatocytes: 13.8;Kupffer cells: 2.0;Proximal enterocytes: 3.6"	"Cancer enriched"	"Detected in single"	209	"liver cancer: 57.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 29: Hepatocytes - Metabolism"															"unprognostic (2.66e-1)"					
MTARC2	"FLJ20605, MARC2, MOSC2"	ENSG00000117791	"Mitochondrial amidoxime reducing component 2"	Q969Z3	1	220748225-220784815	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 132.5;liver: 223.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.6;Proximal enterocytes: 62.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 35.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 14.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.1"	"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015085, HPA017572"	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 40: Non-specific - Enzymes"	"Cluster 29: Hepatocytes - Metabolism"			"HPA015085: AB_1848780, HPA017572: AB_1848778"	"unprognostic (8.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.20e-2)"	"prognostic favorable (1.40e-10)"	"unprognostic (4.78e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (3.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.23e-2)"
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 144.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		170000	"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 36: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"
NLRP2B	"CLRX.1, NALP2P, NLRP2P, NOD24, POP4"	ENSG00000215174	"NLR family pyrin domain containing 2B"	P0DMW2	X	57677067-57680260	"Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		NA	NA					"Cluster 44: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (3.37e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"	"unprognostic (3.84e-2)"		"unprognostic (1.80e-1)"	"unprognostic (5.78e-3)"		"unprognostic (3.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (1.39e-2)"	"unprognostic (7.56e-4)"	"unprognostic (7.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.75e-3)"	"unprognostic (9.00e-2)"
NPBWR1	GPR7	ENSG00000288611	"Neuropeptides B and W receptor 1"	P48145	8	52939182-52943734	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.6;liver: 2.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.9;Hepatocytes: 1.3;Salivary duct cells: 1.0"					"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"				"Low region specificity"	"Detected in some"													NA	NA			"Cluster 49: Eosinophils - Unknown function"		"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"																				
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.2;liver: 48.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 33.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Gastric cancer: 9.0;liver cancer: 7.8"	"Kidney - Proximal tubular cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"			"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913975	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Receptor, Repressor"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.9;liver: 142.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 84.7;Exocrine glandular cells: 34.0;Gastric mucus-secreting cells: 100.2;Hepatocytes: 210.5;Proximal enterocytes: 40.2"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 52.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 13.3;liver cancer: 16.6"	"Kidney - Intercalated cells, Lung - Alveolar cells type 2"	"Region enriched"	"Detected in single"	6	"cerebellum: 1.7"	"Not detected"	"Not detected"			HPA003983			Supported	Nucleoplasm,Vesicles		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	Vesicles	"HPA003983: "	"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 37: Intestine - Unknown function"	"Cluster 48: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039447-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 48.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 29.9;Hepatocytes: 28.5;Kupffer cells: 20.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.4;medulla oblongata: 2.1;pons: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"								"Secreted to blood"	NA	NA	143000000	420000000		"Cluster 85: Liver - Metabolism"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.40e-4)"
PDP2	"KIAA1348, PPM2B, PPM2C2"	ENSG00000172840	"Pyruvate dehyrogenase phosphatase catalytic subunit 2"	Q9P2J9	16	66878589-66895754	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - Alveolar cells type 2, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019950, HPA062059"	Approved		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA019950: AB_1855156, HPA062059: AB_2684671"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.90e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (9.75e-7)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.15e-2)"
PFKFB1	PFRX	ENSG00000158571	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1"	P16118	X	54932961-54998534	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 28.3;liver: 50.2;skeletal muscle: 111.6;tongue: 40.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.2;Hepatocytes: 13.5;Oligodendrocyte precursor cells: 2.4;Oligodendrocytes: 3.0;Skeletal myocytes: 4.9"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 7.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (2.51e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.36e-3)"	"unprognostic (5.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.96e-3)"
PGRMC1	HPR6.6	ENSG00000101856	"Progesterone receptor membrane component 1"	O00264	X	119236245-119244466	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 677.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 479.3;Theca cells: 641.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Colon - Colon enteroendocrine cells, Liver - Hepatocytes, Liver - Hepatocytes, Skin - Sebaceous gland cells, Testis - Leydig cells, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002877, HPA064724"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA		1200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 48: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"	Nucleoli	"HPA002877: AB_1079602, HPA064724: "	"unprognostic (6.97e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.35e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (1.58e-3)"	"unprognostic (9.28e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451263-6556555	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 20.2;Inhibitory neurons: 23.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	23	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Liver - Sinusoid Endothelial cells, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Sarcoma - Muscle contraction"	"Cluster 29: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favorable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 1638.0"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.2"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells"					"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823, HPA053770"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532, HPA053770: AB_2682256"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"
PLGLB1	"PLGL, PRP-B"	ENSG00000183281	"Plasminogen like B1"	Q02325	2	87002559-87021852	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Tissue enriched"	"Detected in all"	6	"liver: 234.9"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 62.8"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"												HPA053770			Approved	Vesicles	"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 15: Liver - Metabolism"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"HPA053770: AB_2682256"	"unprognostic (7.25e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-5)"	"unprognostic (7.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.53e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.56e-4)"	"unprognostic (9.90e-3)"	"unprognostic (2.96e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.98e-5)"
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923792-43964488	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 31.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 33.8;Hepatocytes: 36.1;Rod photoreceptor cells: 35.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Adipocytes (Visceral), Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Skin - Keratinocyte (granular)"	"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"
PPP1R3B	"FLJ14005, GL, PPP1R4"	ENSG00000173281	"Protein phosphatase 1 regulatory subunit 3B"	Q86XI6	8	9136255-9151574	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 144.9;skeletal muscle: 95.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 75.0;Hepatocytes: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"basophil: 53.6;eosinophil: 15.8;neutrophil: 50.4"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 53.6"	"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA028731	Enhanced		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 68: Kidney - Mixed function"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol		"HPA028731: AB_10602120"	"unprognostic (4.97e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.08e-7)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (3.33e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.21e-1)"
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"choroid plexus: 107.5;heart muscle: 116.6;liver: 283.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 264.5;Thymic epithelial cells: 87.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 64.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Fibroblasts, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	5000000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 29: Hepatocytes - Metabolism"			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158648-113172386	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 109.2"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 64.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	NA	NA	1720000000	650000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 85: Liver - Metabolism"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 29: Hepatocytes - Metabolism"			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341662	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 2400.4;liver: 1994.6;pancreas: 1482.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 2599.1;Muller glia cells: 678.5;Thymic epithelial cells: 625.0;Undifferentiated cells: 551.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.4"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 565.3"	"Lung - Fibroblast_1, Pancreas - Exocrine glandular cells, Prostate - Fibroblasts, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	460000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 68: Kidney - Mixed function"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"
RDH16	"RODH-4, SDR9C8"	ENSG00000139547	"Retinol dehydrogenase 16"	O75452	12	56951431-56959374	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"liver: 793.0"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 344.0"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 44.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.6;prostate cancer: 1.6"	"Liver - Hepatocytes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038518	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA038518: AB_10672713"	"unprognostic (5.42e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (2.16e-5)"	"unprognostic (8.83e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.10e-1)"	"unprognostic (7.99e-12)"	"unprognostic (2.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.01e-2)"
RPRD1B	"C20orf77, CREPT, dJ1057B20.2, DKFZp434P0735, FLJ44520, K-H, Kub5-Hera, NET60"	ENSG00000101413	"Regulation of nuclear pre-mRNA domain containing 1B"	Q9NQG5	20	38033725-38127780	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.5"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066290, HPA070590, HPA072645"	Enhanced		Supported	Nucleoplasm		NA	NA		28000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm		"HPA066290: AB_2685650, HPA070590: , HPA072645: "	"unprognostic (3.14e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.47e-1)"
SAA1	"PIG4, SAA, TP53I4"	ENSG00000173432	"Serum amyloid A1"	P0DJI8	11	18266260-18269977	"Disease related genes, Predicted secreted proteins"	"Acute phase"	Heparin-binding	Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 48144.3"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 89372.2"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 1249.6"	"Group enriched"	"Detected in some"	5	"midbrain: 3.8;pons: 2.6;thalamus: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 590.2;Kidney cancer: 254.2"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)"														"Secreted to blood"	NA	NA	300000000	11000000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (2.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (4.57e-12)"	"unprognostic (5.15e-2)"	"unprognostic (9.78e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"
SAA2		ENSG00000134339	"Serum amyloid A2"	P0DJI9	11	18239223-18248668	"Disease related genes, Predicted secreted proteins"	"Acute phase"		Amyloidosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 36265.6"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 44005.0"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 150.5"	"Group enriched"	"Detected in some"	9	"midbrain: 6.3;pons: 4.8;thalamus: 7.7"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"head and neck cancer: 533.7;Kidney cancer: 165.0"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)"														"Secreted to blood"	NA	NA	50000000	9200000000	"Cluster 17: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 60: Keratinocytes - Epithelial cell function"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (1.73e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (1.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"
SC5D	SC5DL	ENSG00000109929	Sterol-C5-desaturase	O75845	11	121292681-121313410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 393.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 300.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Liver - Hepatocytes, Lung - Alveolar cells type 2, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066283, HPA070248"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Nucleoplasm, Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA066283: AB_2685648, HPA070248: AB_2686240"	"unprognostic (4.78e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.98e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (2.79e-2)"	"unprognostic (7.96e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (4.29e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.98e-1)"
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adrenal gland: 995.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 146.9;Granulosa cells: 129.4;Hepatocytes: 150.4;Kupffer cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 6.2;myeloid DC: 8.9;plasmacytoid DC: 21.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 21.0;monocytes: 6.2"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347233-100364826	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1233.7;brain: 839.9;liver: 583.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 486.7;Hepatocytes: 753.3;Kupffer cells: 960.5;Oligodendrocytes: 426.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Testis - Sertoli cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 38798.6"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Group enriched"	"Detected in many"	4	"Gastric cancer: 342.8;liver cancer: 848.0;lymphoma: 256.6"	"Adipose visceral - Neutrophils, Liver - Hepatocytes, Skeletal muscle - Neutrophils"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280460-94293268	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	104	"liver: 346.9"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 219.9"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells, Liver - Hepatocytes, Pancreas - Alpha cells, Stomach - Gastric enteroendocrine cells"	"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA	3960000000	4700000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 41: Non-specific - Cilium assembly"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	Cytosol	"HPA048739: AB_2797237"	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452800	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"liver: 490.6"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 262.5"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	11	"liver cancer: 4.8"	"Breast - Breast glandular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		230000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favorable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"			
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323389	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 776.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 225.2;Endometrial ciliated cells: 73.7;Hepatocytes: 339.3;Kupffer cells: 83.6"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 14.1;liver cancer: 21.6"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA017864	Approved				"Secreted to blood"	NA	NA	60800000000	37000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favorable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032435-106038727	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	612	"liver: 282.2"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 165.2"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"liver cancer: 5.2"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	NA	NA	39800000000	25000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"		
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 1253.1"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 240.8"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"liver cancer: 33.1;ovarian cancer: 108.6"	"Liver - Hepatocytes, Thyroid - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		50000000000	"Cluster 24: B-cells - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755265	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 1578.5"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 824.3;Kupffer cells: 257.5"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 44.7"	"Lineage enriched"	"Detected in many"	23	"dendritic cells: 44.7"	"Group enriched"	"Detected in many"	12	"Gastric cancer: 50.5;liver cancer: 36.5"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001885, HPA005943, CAB024863"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	11900	61000000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB024863: , HPA001885: AB_1079922, HPA005943: "	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.4;Hepatocytes: 4.9;Inhibitory neurons: 1.1;Oligodendrocyte precursor cells: 1.4;Oligodendrocytes: 1.1"	"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									HPA039390	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 29: Hepatocytes - Metabolism"			"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.04e-4)"							"unprognostic (1.01e-1)"			
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369785-63410294	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"liver: 46.3"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 4.9;Hepatocytes: 13.8;Kupffer cells: 4.0"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"liver cancer: 4.2;Myeloma: 1.8"	"Liver - Hepatocytes, Skin - Sebaceous gland cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"									"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367278-22434129	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 551.3;pancreas: 252.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 259.3;Hepatocytes: 493.6;Kupffer cells: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"
SPRN	"bA108K14.1, FLJ41197, Shadoo"	ENSG00000203772	"Shadow of prion protein"	Q5BIV9	10	133420666-133424572	"Predicted intracellular proteins, Transporters"		Prion		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;liver: 17.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.4;Hepatocytes: 17.2;Horizontal cells: 7.7;Kupffer cells: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"												"Intracellular and membrane"	NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 31: Non-specific - Transcription"	"Cluster 29: Hepatocytes - Metabolism"				"unprognostic (2.66e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.58e-7)"
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 228.5;Syncytiotrophoblasts: 301.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: NCI-H716 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.37e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.12e-2)"	"unprognostic (9.51e-3)"	"unprognostic (4.63e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (4.76e-3)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (3.45e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (7.51e-2)"	"prognostic unfavorable (5.70e-4)"	"unprognostic (9.71e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.74e-3)"
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"
ST6GAL1	SIAT1	ENSG00000073849	"ST6 beta-galactoside alpha-2,6-sialyltransferase 1"	P15907	3	186930325-187078553	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 495.9;lymphoid tissue: 148.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 516.1;Kupffer cells: 213.3;Microglial cells: 586.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 70.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 104.1;Myeloma: 146.5"	"Liver - Hepatocytes, Skin - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015018, CAB016122"	Supported				"Secreted to blood"	NA	NA	15000000	3300000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 29: Hepatocytes - Metabolism"			"CAB015018: AB_629203, CAB016122: AB_627178"	"unprognostic (5.85e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.91e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.93e-2)"
STARD4		ENSG00000164211	"StAR related lipid transfer domain containing 4"	Q96DR4	5	111496033-111512590	"Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Outer root sheath cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046177, HPA048081"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 46: Basophils - DNA binding"	"Cluster 9: Intestine - Unknown function"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 29: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA046177: AB_2679570, HPA048081: AB_2680253"	"unprognostic (1.13e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (2.00e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (2.84e-4)"
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 76.0;Respiratory ciliated cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 3: HUVEC & TIME - Signal transduction"	"Cluster 29: Hepatocytes - Metabolism"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"
TADA1	"ADA1, hADA1, HFI1, STAF42, TADA1L"	ENSG00000152382	"Transcriptional adaptor 1"	Q96BN2	1	166856510-166876264	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028651	Approved		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: Non-specific - RNA binding"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm	"Focal adhesion sites, Cytosol"	"HPA028651: AB_10602476"	"unprognostic (9.53e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-2)"
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 347.4"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Cancer enriched"	"Detected in some"	7	"Leukemia: 23.3"	"Liver - Hepatocytes, Stomach - Parietal cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 29: Hepatocytes - Metabolism"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"
THRSP	"Lpgp, LPGP1, S14, SPOT14, THRP"	ENSG00000151365	"Thyroid hormone responsive"	Q92748	11	78063861-78068351	"Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 210.0;liver: 408.9"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 142.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 44.1"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 10.6;lymphoma: 4.2"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040642	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 65: Breast cancer - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm		"HPA040642: AB_10794878"	"unprognostic (1.19e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (3.28e-4)"	"unprognostic (1.69e-3)"
TLCD1		ENSG00000160606	"TLC domain containing 1"	Q96CP7	17	28724348-28727935	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 35.5;Extravillous trophoblasts: 39.1;Syncytiotrophoblasts: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	11	"plasmacytoid DC: 21.7"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Skin - Sebaceous gland cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042366	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 46: Non-specific - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA042366: AB_10794419"	"unprognostic (1.23e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.47e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (9.05e-5)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.93e-2)"
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319200-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.4;pancreas: 322.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 128.5;Cholangiocytes: 127.0;Granulosa cells: 214.1;Hepatocytes: 205.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Sebaceous gland cells, Stomach - Chief cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"
TRIB3	"C20orf97, dJ1103G7.3, TRB3"	ENSG00000101255	"Tribbles pseudokinase 3"	Q96RU7	20	362835-397559	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 47.3;Exocrine glandular cells: 32.4;Hepatocytes: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Skin - Keratinocyte (granular)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015272, HPA055442"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Ovarian cancer RMG-I - Cellular stress response"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm		"HPA015272: AB_1858269, HPA055442: AB_2682818"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (1.70e-4)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (1.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.07e-13)"	"unprognostic (7.62e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.05e-3)"
UGT1A3	UGT1C	ENSG00000243135	"UDP glucuronosyltransferase family 1 member A3"	P35503	2	233729108-233773299	"Cancer-related genes, Enzymes, Predicted membrane proteins"	"Lipid metabolism"	"Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 73.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	6	"liver cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Esophageal cancer: 2.4;Gallbladder cancer: 3.3"	"Liver - Hepatocytes"															NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 61: Liver - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"										"unprognostic (5.15e-2)"	"unprognostic (9.93e-2)"			"unprognostic (2.97e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.04e-4)"	"unprognostic (8.22e-2)"			"unprognostic (2.08e-3)"
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481166-126517773	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	336	"liver: 116.6"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 53.5;Kupffer cells: 15.8"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced					NA	NA		670000		"Cluster 62: Liver - Hemostasis"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 29: Hepatocytes - Metabolism"			"HPA069863: AB_2732143"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"liver: 6039.5"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 4406.1"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 79.3;liver cancer: 130.1"	"Adipose visceral - Mesothelial cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	33000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"
